Clinical Trial Update: A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating alectinib for locally-advanced or metastatic ALK-positive solid tumors; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System
• Colonic Diseases
• Colorectal Neoplasms
• Digestive System Diseases
• Digestive System Neoplasms
• Gastrointestinal Neoplasms
• Intestinal Diseases
• Neoplasms

Drugs mentioned

• Alectinib (alectinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neoplasms, Colorectal Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2023-08-07